115 related articles for article (PubMed ID: 16389986)
21. Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer.
Hoogendoorn WE; Hollema H; van Boven HH; Bergman E; de Leeuw-Mantel G; Platteel I; Fles R; Nederlof PM; Mourits MJ; van Leeuwen FE;
Breast Cancer Res Treat; 2008 Nov; 112(1):99-108. PubMed ID: 18064567
[TBL] [Abstract][Full Text] [Related]
22. [Increase in risk of endometrial carcinoma following treatment of breast carcinoma with tamoxifen].
Dijkhuizen FP; Brölmann HA; Roumen RM; Bastin FH; Heintz AP
Ned Tijdschr Geneeskd; 1995 Nov; 139(46):2393. PubMed ID: 7501085
[No Abstract] [Full Text] [Related]
23. Case of uterine papillary serous carcinoma following tamoxifen treatment that could not be diagnosed during screening.
Maenaka T; Egawa-Takata T; Hisamoto K; Kunishige I; Nishio Y; Tsujimoto M
J Obstet Gynaecol Res; 2014 May; 40(5):1450-4. PubMed ID: 24606575
[TBL] [Abstract][Full Text] [Related]
24. Magnetic resonance imaging of uterine malignancies.
Whitten CR; DeSouza NM
Top Magn Reson Imaging; 2006 Dec; 17(6):365-77. PubMed ID: 17417085
[TBL] [Abstract][Full Text] [Related]
25. Adenomyomatous polyp of the uterus.
Nasu K; Sugano T; Miyakawa I
Int J Gynaecol Obstet; 1995 Mar; 48(3):319-21. PubMed ID: 7781878
[No Abstract] [Full Text] [Related]
26. Magnetic resonance imaging of typical polypoid adenomyoma of the uterus in 8 patients: correlation with pathological findings.
Kitajima K; Imanaka K; Kuwata Y; Hashimoto K; Sugimura K
J Comput Assist Tomogr; 2007; 31(3):463-8. PubMed ID: 17538297
[TBL] [Abstract][Full Text] [Related]
27. Polypoid endometriosis and other benign gynaecological complications associated with Tamoxifen therapy-a case to illustrate features on magnetic resonance imaging.
Kraft JK; Hughes T
Clin Radiol; 2006 Feb; 61(2):198-201. PubMed ID: 16439226
[No Abstract] [Full Text] [Related]
28. Endometrial polyps in postmenopausal patients receiving tamoxifen.
Nuovo MA; Nuovo GJ; McCaffrey RM; Levine RU; Barron B; Winkler B
Int J Gynecol Pathol; 1989; 8(2):125-31. PubMed ID: 2714930
[TBL] [Abstract][Full Text] [Related]
29. [Uterine carcinosarcomas associated with tamoxifen therapy. Report of two cases and review of the literature].
Leung F; Terzibachian JJ; Govyadovskiy A; Bourtembourg A; Aouar Z; Fat BC; Maillet R; Riethmuller D
J Gynecol Obstet Biol Reprod (Paris); 2009 Apr; 38(2):173-8. PubMed ID: 19135318
[TBL] [Abstract][Full Text] [Related]
30. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
[TBL] [Abstract][Full Text] [Related]
31. Uterine changes during tamoxifen therapy.
Rullo S; Tagliaferri T; Bandiera F; Fiorelli C; Felici A; Piccioni MG; Framarino dei Malatesta ML
Clin Exp Obstet Gynecol; 1993; 20(2):116-9. PubMed ID: 8330432
[TBL] [Abstract][Full Text] [Related]
32. Adenosarcoma of the uterus: magnetic resonance imaging characteristics.
Takeuchi M; Matsuzaki K; Yoshida S; Kudo E; Bando Y; Hasebe H; Kamada M; Nishitani H
Clin Imaging; 2009; 33(3):244-7. PubMed ID: 19411035
[TBL] [Abstract][Full Text] [Related]
33. Tamoxifen and the uterus and endometrium.
Neven P; De Muylder X; Van Belle Y; Vanderick G; De Muylder E
Lancet; 1989 Feb; 1(8634):375. PubMed ID: 2563519
[No Abstract] [Full Text] [Related]
34. Endometrial carcinoma following treatment for breast carcinoma in a Nigerian female. A case report and review of the literature.
Abudu EK; Musa O; Adefuye PO; Abdul Kareem FB; Agboola AO; Banjo AA
Niger Postgrad Med J; 2007 Dec; 14(4):355-7. PubMed ID: 18163149
[TBL] [Abstract][Full Text] [Related]
35. Adenomyomatous Polyp of the Endometrium With Prominent Epithelioid Smooth Muscle Differentiation: Report of Two Cases of a Hitherto Undescribed Lesion.
Kenny SL; McCluggage WG
Int J Surg Pathol; 2014 Jun; 22(4):358-63. PubMed ID: 23926192
[TBL] [Abstract][Full Text] [Related]
36. Value of dynamic enhanced magnetic resonance imaging for distinguishing between ovarian fibroma and subserous uterine leiomyoma.
Thomassin-Naggara I; Daraï E; Nassar-Slaba J; Cortez A; Marsault C; Bazot M
J Comput Assist Tomogr; 2007; 31(2):236-42. PubMed ID: 17414760
[TBL] [Abstract][Full Text] [Related]
37. Intracranial ganglioglioma: clinicopathological and MRI findings in 16 patients.
Zhang D; Henning TD; Zou LG; Hu LB; Wen L; Feng XY; Dai SH; Wang WX; Sun QR; Zhang ZG
Clin Radiol; 2008 Jan; 63(1):80-91. PubMed ID: 18068794
[TBL] [Abstract][Full Text] [Related]
38. Adenomyosis in the broad ligament and tamoxifen: report of a case.
Chung YP; Lin HH; Sheu BC; Mao TL; Chang DY; Huang SC
J Obstet Gynaecol Res; 1997 Feb; 23(1):69-73. PubMed ID: 9094821
[TBL] [Abstract][Full Text] [Related]
39. A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women.
Chan SS; Tam WH; Yeo W; Yu MM; Ng DP; Wong AW; Kwan WH; Yuen PM
BJOG; 2007 Dec; 114(12):1510-5. PubMed ID: 17995495
[TBL] [Abstract][Full Text] [Related]
40. Long-term effects of the levonorgestrel-releasing intrauterine system on serum lipids and the endometrium in breast cancer patients taking tamoxifen.
Kesim MD; Aydin Y; Atis A; Mandiraci G
Climacteric; 2008 Jun; 11(3):252-7. PubMed ID: 18568790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
